Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Hair loss in women may have causes other than hormones.

Review finds no permanent solution for female hair loss.

Using 3% topical minoxidil can help women with hair loss, but more research is needed.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Two women had skin reactions from a hair loss treatment and got better after stopping use.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Hair loss has many causes and treatments, and losing some hair daily is normal; proper diagnosis is key, and minoxidil can help treat it.

About 15% of US Army personnel use hair products containing hormone or placenta, with higher usage among non-whites, females, and enlisted personnel.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Review determines effective, safe treatments for female hair loss.

Hair care products with placental growth factor can improve hair thickness and density in postpartum hair loss.

Estrogen affects hair growth and skin cell multiplication.

The estrogen receptor pathway controls hair growth cycles and affects skin cell growth.

The effects of estrogen on human hair growth are unclear and need more research.

Topical finasteride may help treat facial hirsutism in women.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Spironolactone is effective and safe for treating acne with minimal side effects.